D-0339-2021 Class III Terminated
FDA drug recall D-0339-2021 was initiated by Teligent Pharma, Inc. on Feb 2, 2021 and is designated Class III. Reason for recall: Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate. The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 79,416 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- May 5, 2021
- Initiation Date
- Feb 2, 2021
- Termination Date
- Aug 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 79,416 tubes
Product description
Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 50 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-51
Reason for recall
Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.
Distribution pattern
USA Nationwide
Code information
Lot #: 14297, Exp 9/2021; 15757, Exp 6/2022; 15840, Exp 7/2022; 15970, Exp 9/2022; 15993, Exp 9/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0339-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026